Searching for chronic hepatitis B patients in a low prevalence area: role of racial origin (2004)
- Authors:
- USP affiliated authors: NITA, SUZANE KIOKO ONO - FM ; SILVA, LUIZ CAETANO DA - FM ; CARRILHO, FLAIR JOSÉ - FM
- Unidade: FM
- DOI: 10.1186/1471-2296-5-7
- Subjects: HEPATITE C (TRANSMISSÃO); FATORES DE RISCO; DOENÇA CRÔNICA; FAMÍLIA
- Language: Inglês
- Imprenta:
- Source:
- Título: BMC family practice
- ISSN: 1471-2296
- Volume/Número/Paginação/Ano: v. 5:7, p.1-6, 2004
- Este periódico possui versão em acesso aberto
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão: publishedVersion
- Evidência: deprecated
- Status do Acesso Aberto: gold
-
ABNT
NITA, Euzane Kioko Ono et al. Searching for chronic hepatitis B patients in a low prevalence area: role of racial origin. BMC family practice, v. 5:7, p. 1-6, 2004Tradução . . Disponível em: https://doi.org/10.1186/1471-2296-5-7. Acesso em: 10 mar. 2026. -
APA
Nita, E. K. O., Carrilho, F. J., Cardoso, R. A., Nita, M. E., & Silva, L. C. da. (2004). Searching for chronic hepatitis B patients in a low prevalence area: role of racial origin. BMC family practice, 5:7, 1-6. doi:10.1186/1471-2296-5-7 -
NLM
Nita EKO, Carrilho FJ, Cardoso RA, Nita ME, Silva LC da. Searching for chronic hepatitis B patients in a low prevalence area: role of racial origin [Internet]. BMC family practice. 2004 ; 5:7 1-6.[citado 2026 mar. 10 ] Available from: https://doi.org/10.1186/1471-2296-5-7 -
Vancouver
Nita EKO, Carrilho FJ, Cardoso RA, Nita ME, Silva LC da. Searching for chronic hepatitis B patients in a low prevalence area: role of racial origin [Internet]. BMC family practice. 2004 ; 5:7 1-6.[citado 2026 mar. 10 ] Available from: https://doi.org/10.1186/1471-2296-5-7 - Cinética viral e resultados tardios do tratamento com consensus interferon a (CIFN) e ribavirina (RB) em pacientes com hepatite crônica C (HC-C) previamente resistentes à associação com IFN a e RB
- Rapid and profound drop HCV RNA viremia induced by high dose of consensus IFN (CIFN) just before starting pegylated interferon (PEG-IFN) plus ribavirin (RBV) in chronic hepatitits C patients (pts) previously resistant to combined therapy (IFN+RBV): preliminary report
- Unpredictable outcome in lamivudine (LAM): resistant patients under high daily doses & early effects of combined therapy of lam plus pegylated interferon
- A phylogenetic study of hepatitis B virus in chronically infected Brazilian patients of Western and Asian descent
- High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study
- A twelve-week period of follow-up after an end of treatment response (ETR) in patients with chronic hepatitis C (CH-C) submitted to combined therapy is a reliable period to characterize a sustained response
- Rapid and profound drop of HCV RNA viraemia induced by high dose of consensus interferon just before starting pegylated interferon plus ribavirin in chronic hepatitis C patients previously resistant to combined therapy:: preliminary report.
- A twelve-week period of follow-up after an end-of-treatment response in patients with chronic hepatitis C submitted to combined therapy is a reliable period to characterize a sustained response.
- A prospective study of the prevalence of hepatitis B and C virus co-infection among patients with chronic renal disease under hemodialysis
- Tratamento das hepatites virais B e D
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
